Source: International Congress 2019 – Severe acute asthma and troublesome wheezing
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Davies (Birmingham, United Kingdom), D. Chinthala (Birmingham, United Kingdom), S. Frost (Birmingham, United Kingdom), I. Brookes (Birmingham, United Kingdom), P. Kenia (Birmingham, United Kingdom), S. Rao (Birmingham, United Kingdom), P. Nagakumar (Birmingham, United Kingdom). Mepolizumab eligibility in children with severe asthma – do we need paediatric specific criteria?. 950

Member's Comments

No comment yet.

Related content which might interest you: Treatment eligibility of mepolizumab-treated severe asthma patients in clinical practice Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Identifying patients with severe allergic asthma who are potentially eligible for omalizumab treatment by EU licence and NICE guidance criteria Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy Year: 2008 Spanish study on unmet clinical needs in patients with uncontrolled severe asthma. Source: International Congress 2018 – Asthma management Year: 2018 Useful malnutrition diagnostic criteria for stable COPD in Japanese patients Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD Year: 2020 Examining the unmet need in adults with severe asthma Source: Eur Respir Rev 2007; 16: 67-72 Year: 2007 The prevalence of severe asthma in specialist care –identifying eligible candidates for biological therapies Source: International Congress 2017 – Clinical points to ponder in asthma Year: 2017 Managing asthma in the outpatient clinic: Is the diagnosis of asthma confirmed objectively according to guidelines? Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Real-world patient characteristics and eligibility for biologics in severe asthma (RECOGNISE) Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 The need for a specialist multidisciplinary clinic to manage paediatric patients with severe asthma in the age of biologics Source: International Congress 2019 – PG11 Severe paediatric asthma Year: 2019 Is mild asthma outside the guidelines? Source: Annual Congress 2011 - Asthma: control and treatment Year: 2011 Evaluation of a diagnostic–therapeutic pathway on GINA guidelines between specialist and primary care physicians. Study and result at 1 year in children with asthma Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma Year: 2008 Need for generalized criteria in evaluating the impact of new drugs in clinical trials involving patients suffering from COPD Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers Year: 2006 From guidelines to personalized treatment of children with asthma Source: Virtual Congress 2020 – Which paediatric asthma guidelines are the most appropriate for children and adolescents? Year: 2020 Occupational asthma audit criteria - do they meet the needs of UK specialist clinicians? Source: International Congress 2019 – Environment, work and respiratory health in occupational and environmental lung diseases Year: 2019 Prevalence of asthma in preschool children with different diagnostic criteria Source: Annual Congress 2007 - Epidemiology of paediatric asthma: genes, environment and prognosis Year: 2007 Screening for COPD and asthma in acutely admitted psychiatric patients: feasible and with a low number of patients needed to screen. Source: International Congress 2017 – Best abstracts in physical activity and management of COPD Year: 2017 How should asthma be diagnosed in school children? Recommendations of the evidence based ERS-Guidelines Source: Virtual Congress 2021 – The ERS guidelines for the diagnosis of asthma in children aged 5-16 years Year: 2021 Is there a need for pharmacoepidemiology in asthma and COPD? Source: Annual Congress 2004 - Pharmacoepidemiology of obstructive lung disease: beyond clinical trials Year: 2004 Defining acute asthma severity – how do worldwide asthma guidelines compare? Source: International Congress 2018 – The bad and the ugly in paediatric asthma: comorbidities and exacerbations Year: 2018